Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus.
Current post-exposure prophylaxis for rabies virus infection has several limitations in terms of supply, cost, safety, and efficacy. Attempts to replace human or equine rabies immune globulins (HRIG or ERIG) have been made by several companies and institutes. We developed potent monoclonal antibodie...
Main Authors: | Pan Kyeom Kim, Sun Ju Keum, Modupe O V Osinubi, Richard Franka, Ji Young Shin, Sang Tae Park, Man Su Kim, Mi Jung Park, Soo Young Lee, William Carson, Lauren Greenberg, Pengcheng Yu, Xiaoyan Tao, Wang Lihua, Qing Tang, Guodong Liang, Madhusdana Shampur, Charles E Rupprecht, Shin Jae Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5646816?pdf=render |
Similar Items
-
Antemortem diagnosis and prevention of human rabies
by: Madhusudana Shampur, et al.
Published: (2008-01-01) -
In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants
by: Richard Franka, et al.
Published: (2017-09-01) -
Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.
by: Thomas Müller, et al.
Published: (2009-01-01) -
Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
by: Thomas Müller, et al.
Published: (2009-11-01) -
Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans.
by: Thomas Müller, et al.
Published: (2009-11-01)